102 Bd Carl-Vogt
Genève, CH - 1205
Switzerland
University of Geneva
Pandemic influenza vaccine, adjuvant, Hybrid PLGA nanoparticle, tomatine saponin, NOD2 agonists, formulation, immunogenicity